SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(Amendment No. 1)
(Mark One)
|
x |
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES |
For the fiscal year ended December 31, 2005
OR
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES |
For the transition period from to .
Commission File Number 333-116038
SYMMETRY MEDICAL INC.
(Exact name of Registrant as Specified in its Charter)
|
Delaware |
|
35-1996126 |
|
(State or Other Jurisdiction of |
|
(I.R.S. Employer |
|
220 W. Market Street, Warsaw, Indiana |
|
46580 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: (574) 268-2252
Securities Registered Pursuant to Section 12(b) of the Act:
|
Title of Each Class |
|
Name of Exchange on Which Registered |
|
Common Stock, $0.0001 par value |
|
New York Stock Exchange |
Securities Registered Pursuant to Section 12(g) of the Act:
None
(Title of Class)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicated by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to the Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act. Large accelerated filer o Accelerated filer x Non accelerated filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x
Table of Contents
DOCUMENTS INCORPORATED BY REFERENCE
None.
EXPLANATORY NOTE
Symmetry Medical, Inc. (the “Company”) hereby amends its Annual Report on Form 10-K for the year ended December 31, 2005 for the sole purpose of updating the Exhibits included within Part IV, Item 15 to include the audited financial statements for the Company’s 2004 Employee Stock Purchase Plan which is described in Part II, of Form 10-K for year ended December 31, 2005.
Items in the Annual Report on Form 10-K not referenced below are not amended, and this amendment does not reflect events occurring after the original filing of the Annual Report on Form 10-K, or modify or update those disclosures as presented in the Form 10-K except to the extent set forth herein. Items referenced herein are amended as set forth below.
2
Part IV
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
3. Exhibits:
|
Exhibit Number |
|
Description |
|
|
|
|
|
10.1 |
|
Audited Financial Statements of Symmetry Medical Inc. 2004 Employee Stock Purchase Plan for the year ended December 31, 2005. |
|
|
|
|
|
23.1 |
|
Consent of Independent Registered Public Accounting Firm, BKD, LLP |
|
|
|
|
|
23.2 |
|
Consent of Independent Registered Public Accounting Firm, Ernst & Young, LLP |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
SYMMETRY MEDICAL INC. |
|
|
|
|
|
|
|
May 1, 2006 |
|
By: |
/s/ BRIAN MOORE |
|
|
|
|
Chief Executive Officer and President |
3